PROFUND ADVISORS LLC

Position in AVXL — Anavex Life Sciences Corp.

CIK 1129919 BETHESDA, MD

Position in AVXL

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$197,164

-$9,216 QoQ

Shares Held

64,223

+10.8% QoQ

Ownership

0.069%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

PROFUND ADVISORS LLC holds $183,565,563 across 158 Biotechnology names. AVXL ranks #150 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	23,137	$10,331,595
2	REGN	Regeneron Pharmaceuticals, Inc.	10,332	$7,982,916
3	ALNY	Alnylam Pharmaceuticals, Inc.	14,647	$4,846,252
4	INSM	INSMED Inc	27,937	$4,568,258
5	APLS	Apellis Pharmaceuticals, Inc.	81,190	$3,266,273
6	MDGL	Madrigal Pharmaceuticals, Inc.	4,862	$2,545,111
7	TGTX	Tg Therapeutics, Inc.	76,039	$2,526,015
8	ARWR	Arrowhead Pharmaceuticals, Inc.	39,758	$2,492,826

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$197,164	64,223	+10.8%	Shares	Sole	2026-04-27
2025-12-31	$206,380	57,972	+142.6%	Shares	Sole	2026-02-06
2025-09-30	$212,710	23,900	+20.4%	Shares	Sole	2025-11-06
2025-06-30	$183,044	19,853	-25.4%	Shares	Sole	2025-08-07
2025-03-31	$228,399	26,620	+73.1%	Shares	Sole	2025-05-08
2024-12-31	$165,181	15,380	-45.0%	Shares	Sole	2025-02-14
2024-09-30	$158,886	27,973	-32.2%	Shares	Sole	2024-11-14
2024-06-30	$174,201	41,280	-59.9%	Shares	Sole	2024-08-13
2024-03-31	$524,463	103,038	+168.5%	Shares	Sole	2024-05-08
2023-12-31	$357,224	38,370	-16.5%	Shares	Sole	2024-02-14
2023-09-30	$301,070	45,965	-27.8%	Shares	Sole	2023-11-13
2023-06-30	$517,507	63,654	-25.9%	Shares	Sole	2023-08-10
2023-03-31	$736,265	85,912	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.